Evidence map›Paper›PMID 30569026›Full record

ReviewIBRO reports2018

Genetics of Glioblastoma in Moroccan population: Review of literature.

Hossam Hilal El Idrissi, Oum Kaltoum Ait Boujmia, Sellama Nadifi, Hind Dehbi

Open access · goldAbstract readReview
In one paragraph

Review in IBRO reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Hossam Hilal El IdrissiLaboratory of Genetics and Molecular Pathology, Medical School, University Hassan II, Casablanca, Morocco.
Oum Kaltoum Ait BoujmiaLaboratory of Genetics and Molecular Pathology, Medical School, University Hassan II, Casablanca, Morocco.
Sellama NadifiLaboratory of Genetics and Molecular Pathology, Medical School, University Hassan II, Casablanca, Morocco.
Hind DehbiLaboratory of Genetics and Molecular Pathology, Medical School, University Hassan II, Casablanca, Morocco.
University of Hassan II Casablanca · MA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glioblastoma is the most aggressive malignant type of central nervous system tumors. The literature review revealed that the most common genetic abnormalities in primary and secondary glioblastomas are IDH1 / 2 mutations, p53 mutations, and overexpression of EGFR. To our knowledge, this is the first Moroccan study to provide a global picture of genetic studies performed on Moroccan patients to describe genetic markers and their frequency in our population. An in-depth research in ScienceDirect and Pubmed on glioblastoma articles treated in Morocco, this research is based on the following keywords: glioblastoma in Morocco, primary glioblastoma in Morocco, secondary glioblastoma in Morocco. We found only three research articles on genomic alteration of IDH1 / 2, p53 and EGFR expression. The frequency of these gene mutations in our population was similar to those reported from other populations. Additional molecular studies need to be performed on other genes to describe other genetic markers in the Moroccan population.

Indexed as

EGFRIDH1 and IDH2P53Primary and secondary glioblastoma Morocco

Identifiers

PMID30569026
PMCPMC6287047
OpenAlexW2901105540

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.